Lf Clark, Jc Bilbie, P. Abraham
{"title":"What do patients prefer: insulin pumps or multiple daily injections and structured education?","authors":"Lf Clark, Jc Bilbie, P. Abraham","doi":"10.1002/PDI.1561","DOIUrl":null,"url":null,"abstract":"Potential advantages of continuous subcutaneous insulin infusion (CSII) over multiple daily injections (MDI) include improved glycaemia, and reduced frequency and severity of hypoglycaemia. In our hospital, to be considered for CSII, patients must be using MDI, and then undergo a Dose Adjustment For Normal Eating (DAFNE) structured education course. \n \n \n \nWe reviewed the records of the 21 patients with type 1 diabetes who had sequentially undergone MDI, then DAFNE and are now treated with CSII. \n \n \n \nHbA1c improved as patients increased the intensity of the management of diabetes despite reductions in total daily insulin dose. Patients did a similar number of home blood glucose tests per day and spent a similar amount of time managing their diabetes. \n \n \n \nContacts with health care team members were the same for all modalities in the first three months but reduced for those on MDI with or without having completed a structured education course, while contacts with the health care team remained higher on pumps. Patients were generally satisfied with all modalities of treatment and would recommend each modality. \n \n \n \nThe input into the management of diabetes from both patients and health care professionals remained high even after the initial stages of being commenced on CSII therapy. This reflects the additional input needed in assessing the various basal rates and other ratios. However, patient preference was in favour of pumps in this select group who had sequentially experienced all three options. Copyright © 2011 John Wiley & Sons.","PeriodicalId":92116,"journal":{"name":"Practical diabetes international : the journal for diabetes care teams worldwide","volume":"3 4","pages":"73"},"PeriodicalIF":0.0000,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/PDI.1561","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical diabetes international : the journal for diabetes care teams worldwide","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/PDI.1561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
患者更喜欢什么:胰岛素泵还是每天多次注射和有组织的教育?
持续皮下胰岛素输注(CSII)相对于多次每日注射(MDI)的潜在优势包括改善血糖,降低低血糖的频率和严重程度。在我院,考虑CSII的患者必须使用MDI,然后接受正常饮食剂量调整(DAFNE)结构化教育课程。我们回顾了21例1型糖尿病患者的记录,这些患者先后接受了MDI、DAFNE和CSII治疗。尽管每日胰岛素总剂量降低,但随着患者糖尿病管理强度的增加,HbA1c有所改善。患者每天在家做的血糖测试次数相似,治疗糖尿病的时间也相似。在前三个月,所有方式的人与保健小组成员的接触都是相同的,但无论是否完成了结构化教育课程,接受MDI的人与保健小组成员的接触都有所减少,而接受泵治疗的人与保健小组的接触仍然较多。患者普遍对所有治疗方式感到满意,并会推荐每种治疗方式。即使在开始CSII治疗的初始阶段之后,患者和卫生保健专业人员对糖尿病管理的投入仍然很高。这反映了在评估各种基本比率和其他比率时需要额外的投入。然而,在这个连续经历了所有三种选择的选择组中,患者偏好于支持泵。版权所有©2011 John Wiley & Sons。
本文章由计算机程序翻译,如有差异,请以英文原文为准。